It was these findings that paved the way for the use of mTOR inhibitors as potential therapies for mitochondrial disease (Johnson et al., 2013; Sage-Schwaede et al., 2019; Cheema et al., 2021). This evidence concerns the gene MTOR and mitochondrial disease.